Answers are grounded in this paper and cite their sources.
Systematic review evaluates EMG-driven rehabilitation vs conventional therapy in post-stroke populations, implying no significant advantage.
Surface electromyography (EMG) can drive assistive training systems in neurorehabilitation. This systematic review and meta-analysis evaluated whether EMG-driven device-assisted rehabilitation improves upper-limb (UL) and lower-limb (LL) outcomes versus conventional therapy (CT). The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and was registered in PROSPERO (CRD420251029642). We searched databases for randomized controlled trials in adults with neurological disorders; three reviewers screened records, extracted data, and assessed risk of bias using the Revised Cochrane risk-of-bias tool (RoB 2). Seven trials (n = 160) were included, all in post-stroke populations (UL: 3; LL: 4). UL trials showed mixed findings, and pooled effects were imprecise and not statistically significant for activities of daily living (ADL) (standardized mean difference, SMD −0.55; p = 0.09; I2 = 0%). LL pooled estimates showed no significant differences in motor function (Fugl-Meyer Assessment, lower extremity, FMA-LE) (mean difference, MD −1.69; p = 0.40), walking independence (Functional Ambulation Categories, FAC) (MD −0.24; p = 0.61), balance (SMD 0.12; p = 0.61), mobility (Timed Up and Go, TUG) (MD −3.24; p = 0.71), or endurance (SMD −0.19; p = 0.43). Current evidence does not demonstrate clinical superiority over CT. EMG-driven systems may be used as an adjunct, but larger trials with standardized protocols, implementation outcomes, and neurological pathologies beyond stroke are needed.
No takes yet. Share an insight, caveat, or question.
Kiper et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: